Hem-1 regulates protective humoral immunity and limits autoantibody production in a B cell-specific manner.
Hem-1 regulates protective humoral immunity and limits autoantibody production in a B cell-specific manner.
复制标题
DOI:
10.1172/jci.insight.153597
复制
发表时间:
2022-05-09
期刊:
影响因子:
8
通讯作者:
Iritani, Brian M.
中科院分区:
文献类型:
--
作者:
Avalos, Alan;Tietsort, Jacob T.;Suwankitwat, Nutthakarn;Woods, Jonathan D.;Jackson, Shaun W.;Christodoulou, Alexandra;Morrill, Christopher;Liggitt, H. Denny;Zhu, Chengsong;Li, Quan-Zhen;Bui, Kevin K.;Park, Heon;Iritani, Brian M.
Hematopoietic protein-1 (Hem-1) is a member of the actin-regulatory WASp family verprolin homolog (WAVE) complex. Loss-of-function variants in the NCKAP1L gene encoding Hem-1 were recently discovered to result in primary immunodeficiency disease (PID) in children, characterized by poor specific Ab responses, increased autoantibodies, and high mortality. However, the mechanisms of how Hem-1 deficiency results in PID are unclear. In this study, we utilized constitutive and B cell–specific Nckap1l-KO mice to dissect the importance of Hem-1 in B cell development and functions. B cell–specific disruption of Hem-1 resulted in reduced numbers of recirculating follicular (FO), marginal zone (MZ), and B1 B cells. B cell migration in response to CXCL12 and -13 were reduced. T-independent Ab responses were nearly abolished, resulting in failed protective immunity to Streptococcus pneumoniae challenge. In contrast, T-dependent IgM and IgG2c, memory B cell, and plasma cell responses were more robust relative to WT control mice. B cell–specific Hem-1–deficient mice had increased autoantibodies against multiple autoantigens, and this correlated with hyperresponsive BCR signaling and increased representation of CD11c+T-bet+ age-associated B cell (ABC cells) — alterations associated with autoimmune diseases. These results suggest that dysfunctional B cells may be part of a mechanism explaining why loss-of-function Hem-1 variants result in recurring infections and autoimmunity.
登录
查看更多内容
DOI:
10.1084/jem.20192275
发表时间:
2020-12-07
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Castro CN;Rosenzwajg M;Carapito R;Shahrooei M;Konantz M;Khan A;Miao Z;Groß M;Tranchant T;Radosavljevic M;Paul N;Stemmelen T;Pitoiset F;Hirschler A;Nespola B;Molitor A;Rolli V;Pichot A;Faletti LE;Rinaldi B;Friant S;Mednikov M;Karauzum H;Aman MJ;Carapito C;Lengerke C;Ziaee V;Eyaid W;Ehl S;Alroqi F;Parvaneh N;Bahram S
通讯作者:
Bahram S
DOI:
10.1084/jem.20151724
发表时间:
2016-05-02
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Jackson SW;Jacobs HM;Arkatkar T;Dam EM;Scharping NE;Kolhatkar NS;Hou B;Buckner JH;Rawlings DJ
通讯作者:
Rawlings DJ
DOI:
10.1056/nejmoa1413462
发表时间:
2015-06-18
期刊:
The New England journal of medicine
影响因子:
--
作者:
Dobbs K;Domínguez Conde C;Zhang SY;Parolini S;Audry M;Chou J;Haapaniemi E;Keles S;Bilic I;Okada S;Massaad MJ;Rounioja S;Alwahadneh AM;Serwas NK;Capuder K;Çiftçi E;Felgentreff K;Ohsumi TK;Pedergnana V;Boisson B;Haskoloğlu Ş;Ensari A;Schuster M;Moretta A;Itan Y;Patrizi O;Rozenberg F;Lebon P;Saarela J;Knip M;Petrovski S;Goldstein DB;Parrott RE;Savas B;Schambach A;Tabellini G;Bock C;Chatila TA;Comeau AM;Geha RS;Abel L;Buckley RH;İkincioğulları A;Al-Herz W;Helminen M;Doğu F;Casanova JL;Boztuğ K;Notarangelo LD
通讯作者:
Notarangelo LD
DOI:
10.1084/jem.20091489
发表时间:
2010-04-12
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Henderson RB;Grys K;Vehlow A;de Bettignies C;Zachacz A;Henley T;Turner M;Batista F;Tybulewicz VL
通讯作者:
Tybulewicz VL
影响因子:
7.3
作者:
Bacalao MA;Satterthwaite AB
通讯作者:
Satterthwaite AB